Last reviewed · How we verify
Moxifloxacin Hydrochloride Tablets — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Moxifloxacin Hydrochloride Tablets (Moxifloxacin Hydrochloride Tablets) — Guangdong Hengrui Pharmaceutical Co., Ltd.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Moxifloxacin Hydrochloride Tablets TARGET | Moxifloxacin Hydrochloride Tablets | Guangdong Hengrui Pharmaceutical Co., Ltd | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Moxifloxacin Hydrochloride Tablets CI watch — RSS
- Moxifloxacin Hydrochloride Tablets CI watch — Atom
- Moxifloxacin Hydrochloride Tablets CI watch — JSON
- Moxifloxacin Hydrochloride Tablets alone — RSS
Cite this brief
Drug Landscape (2026). Moxifloxacin Hydrochloride Tablets — Competitive Intelligence Brief. https://druglandscape.com/ci/moxifloxacin-hydrochloride-tablets. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab